Hindustan Bio Sciences Limited (BSE: 532041)
Health Care · Biotechnology · IN
Rs7.10
-4.70% today · -13.9% 1Y
Hindustan Bio Sciences Limited (BSE: 532041) operates in the Biotechnology industry within the Health Care sector. The company is valued at $766.86K.
Over the last twelve months the share price has lost 13.9%, trading between 5.00 and 9.92.
Tweenvest scores Hindustan Bio Sciences Limited across four factors: quality 45/100, value 56/100, growth 0/100. Its strongest factor is value.
532041 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $766.86K
- Revenue (TTM)
- $42.53K
- P/E
- —
- EPS
- -0.23
- Dividend yield
- —
- Beta (5Y)
- -0.64
- 52-week high
- Rs9.92
- 52-week low
- Rs5.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.25M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Epigenomics AGDB: ECX | $858.33K | €0.87 | -1.14% |
| Silexion Therapeutics CorpNasdaqCM: SLXN | $850.72K | $0.15 | -28.70% |
| Alligator Bioscience AB (publ)OM: ATORX | $837.19K | Skr0.01 | -13.73% |
| Agentix Corp.OTCPK: AGTX | $801.34K | $0.02 | — |
| Decoy Therapeutics Inc.NasdaqCM: DCOY | $766.57K | $1.17 | -20.41% |
| Helix BioMedix, Inc.OTCPK: HXBM | $739.29K | $— | — |
| Smart Agro - LimitedTASE: SMAG | $731.90K | ₪0.54 | -1.29% |
| Nutra Pharma Corp.OTCPK: NPHC | $715.97K | $0.00 | +9900.00% |
Figures last refreshed Oct 18, 2026.